Form 4: BNY Mellon Director Elizabeth Robinson Receives Stock Units

Director Elizabeth Robinson was granted 1,592 deferred stock units by Bank of New York Mellon Corp.

Summary

• Director Elizabeth Robinson acquired 1,592 deferred stock units (DSUs) on April 17, 2026.
• The DSUs are granted on a 1-for-1 basis relative to common stock.
• Following this transaction, the director holds a total of 37,892.107 shares/units.
• The units vest on the earlier of the 2027 Annual Meeting or one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Value of deferred stock units is subject to market fluctuations in BNY Mellon common stock.

Future Outlook

The deferred stock units will vest on the earlier of the 2027 Annual Meeting of Shareholders or one year from the grant date, with payout occurring upon termination of service.

Management Comments

• The transaction reflects standard director compensation practices involving deferred stock units.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the financial services sector to ensure long-term alignment with shareholder interests.

Comparison to Industry Standards

• The grant of deferred stock units is consistent with compensation structures at major financial institutions like JPMorgan Chase, State Street, and Citigroup.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation disclosure.

Next Steps

• Vesting of the 1,592 deferred stock units by the 2027 Annual Meeting of Shareholders.

Key Dates

Keywords

BNY Mellon, BK, Form 4, Insider Transaction, Director Compensation, Equity Grant